0001438133-21-000228.txt : 20211209 0001438133-21-000228.hdr.sgml : 20211209 20211209162410 ACCESSION NUMBER: 0001438133-21-000228 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211207 FILED AS OF DATE: 20211209 DATE AS OF CHANGE: 20211209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gasser Elizabeth Anne CENTRAL INDEX KEY: 0001866283 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 211482267 MAIL ADDRESS: STREET 1: C/O TANDEM DIABETES CARE, INC. STREET 2: 11075 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 4 1 wf-form4_163908503560052.xml FORM 4 X0306 4 2021-12-07 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001866283 Gasser Elizabeth Anne C/O TANDEM DIABETES CARE, INC. 11075 ROSELLE STREET SAN DIEGO CA 92121 0 1 0 0 EVP, Chief Strategy Officer Common Stock 2021-12-07 4 M 0 797 89.54 A 1228 D Common Stock 2021-12-07 4 M 0 286 82.34 A 1514 D Common Stock 2021-12-07 4 S 0 1083 140 D 431 D Stock Option 89.54 2021-12-07 4 M 0 797 89.54 A Common Stock 797.0 21514 D Stock Option 82.34 2021-12-07 4 M 0 286 82.34 A Common Stock 286.0 8601 D Represents shares of common stock received upon exercise of a stock option award. The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. The options vested as to twenty-five (25%) of the underlying shares on 2/18/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). The expiration date for these options is 10 years from the date of grant. The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. s/ David B. Berger, Attorney-in-Fact for Elizabeth A. Gasser 2021-12-09